Fecal Egg Count Reduction Test for Anthelmintic Resistance
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- The Fecal Egg Count Reduction Test (FECRT) is the primary in vivo diagnostic tool for detecting anthelmintic resistance (AR) in gastrointestinal nematodes (GINs) of livestock, assessing drug efficacy by comparing nematode egg counts per gram of feces (EPG) before and after treatment.
- Resistance is defined as a heritable reduction in parasite susceptibility to a previously effective drug, with WAAVP guidelines establishing thresholds: >95% reduction indicates susceptibility, 90-95% suspect resistance, and <90% resistance for most GINs in ruminants.
- Modern FECRT methodology emphasizes standardized protocols including pre-treatment sampling of at least 10-15 animals with EPG >150, accurate drug dosing based on body weight, and post-treatment sampling 10-14 days later, with advanced statistical analysis using geometric means or generalized linear mixed models (GLMM) recommended over simple arithmetic means.
- Numerous factors can confound FECRT results, including host factors (age, immunity, nutrition), parasite species-specific drug susceptibility, drug formulation and administration route (e.g., pour-on vs. injectable), and environmental reinfection pressure from contaminated pastures.
- Complementary diagnostic approaches, such as molecular confirmation of resistance genes (e.g., β-tubulin SNPs for benzimidazoles) and in vitro assays (larval development assay, egg hatch assay), are increasingly used to confirm FECRT findings and provide a more comprehensive understanding of AR.
- The FECRT is crucial for monitoring the efficacy of targeted selective treatment (TST) programs, which aim to reduce anthelmintic use by treating only affected animals, thereby helping to slow the development of AR while maintaining productivity.
Introduction
Anthelmintic resistance (AR) in gastrointestinal nematodes (GINs) of livestock is a globally recognized threat to animal health and productivity [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The fecal egg count reduction test (FECRT) remains the primary in vivo diagnostic tool for detecting AR in the field [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The test compares the number of nematode eggs per gram of feces (EPG) before and after administration of an anthelmintic drug, providing a direct measure of drug efficacy under natural infection conditions [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. The World Association for the Advancement of Veterinary Parasitology (WAAVP) has established standardized guidelines for FECRT conduct and interpretation, which have been updated to incorporate modern statistical methods [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. This article provides an exhaustive technical review of the FECRT, including its biological basis, methodological requirements, statistical analysis, and integration with complementary diagnostic approaches.
Biological and Pharmacological Basis of the FECRT
The FECRT relies on the principle that an effective anthelmintic will eliminate a substantial proportion of adult nematodes residing in the gastrointestinal tract, thereby reducing the number of eggs shed in feces [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. The reduction in EPG is expressed as a percentage relative to the pre-treatment count. Resistance is defined as a heritable reduction in the susceptibility of a parasite population to a drug that was previously effective [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>]. The test does not directly measure drug efficacy against all life stages; it primarily reflects activity against adult egg-laying females [<a href="#ref-19">19</a>, <a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. However, for most GINs, adulticidal efficacy correlates well with overall drug performance [<a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>].
The pharmacokinetics of the anthelmintic class influence the timing of post-treatment sampling. For benzimidazoles (e.g., albendazole, fenbendazole), the drug binds to parasite β-tubulin, inhibiting microtubule polymerization and disrupting cellular processes [<a href="#ref-8">8</a>, <a href="#ref-13">13</a>, <a href="#ref-25">25</a>]. For macrocyclic lactones (e.g., ivermectin, eprinomectin), the drug potentiates glutamate-gated chloride channels, causing paralysis and death [<a href="#ref-7">7</a>, <a href="#ref-17">17</a>, <a href="#ref-26">26</a>]. The rate of egg clearance depends on drug absorption, distribution, and the parasite's location. For example, Haemonchus contortus, a blood-feeding abomasal nematode, may be cleared more rapidly than intestinal species such as Cooperia spp. [<a href="#ref-4">4</a>, <a href="#ref-20">20</a>, <a href="#ref-27">27</a>]. Short-term fasting of the host can enhance the efficacy of certain benzimidazoles by increasing drug bioavailability, as demonstrated in sheep infected with benzimidazole-resistant H. contortus [<a href="#ref-13">13</a>].
Methodology
The FECRT protocol involves three essential phases: pre-treatment sampling, treatment administration, and post-treatment sampling. The interval between sampling points is typically 10 to 14 days, depending on the drug class and parasite species [<a href="#ref-5">5</a>, <a href="#ref-10">10</a>, <a href="#ref-11">11</a>].
Pre-treatment Sampling
A minimum of 10 to 15 animals per treatment group is recommended to achieve adequate statistical power [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-11">11</a>]. Individual fecal samples are collected per rectum or from the ground immediately after defecation. Samples must be processed within 24 hours or refrigerated to prevent egg development [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>, <a href="#ref-14">14</a>]. The pre-treatment EPG should exceed a threshold (commonly 150 EPG for sheep and goats, 50 EPG for cattle) to ensure reliable reduction estimates [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-22">22</a>].
Treatment Administration
The anthelmintic is administered at the manufacturer's recommended dose, preferably based on accurate individual body weight [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-17">17</a>]. Oral drenches, injectable formulations, and pour-on applications are common routes. The route can significantly affect efficacy; for example, pour-on eprinomectin may show reduced efficacy against H. contortus compared to injectable formulations in goats [<a href="#ref-26">26</a>]. In horses, oral paste formulations of pyrantel and fenbendazole are standard [<a href="#ref-10">10</a>, <a href="#ref-21">21</a>, <a href="#ref-23">23</a>].
Post-treatment Sampling
Post-treatment samples are collected at the same time of day as pre-treatment samples to minimize diurnal variation in egg excretion [<a href="#ref-1">1</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. The recommended interval is 10 to 14 days for most GINs, but for drugs with prolonged activity (e.g., macrocyclic lactones), a 14-day interval is preferred to avoid measuring residual drug effects [<a href="#ref-4">4</a>, <a href="#ref-18">18</a>, <a href="#ref-24">24</a>].
Egg Counting Techniques
Several quantitative egg counting methods are used in FECRT. The modified McMaster technique is the most widely employed, with a sensitivity of 15 to 50 EPG depending on the protocol [<a href="#ref-2">2</a>, <a href="#ref-5">5</a>, <a href="#ref-14">14</a>]. The FLOTAC and Mini-FLOTAC methods offer higher sensitivity (down to 1 EPG) and are increasingly recommended for low-shedding animals [<a href="#ref-9">9</a>, <a href="#ref-11">11</a>, <a href="#ref-28">28</a>]. Automated counting systems based on image analysis are under development but not yet standard [<a href="#ref-20">20</a>, <a href="#ref-29">29</a>]. The choice of method affects the precision of EPG estimates and consequently the confidence intervals around the reduction percentage [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-30">30</a>].
Statistical Analysis and Interpretation
The percent reduction (PR) is calculated using the formula:
PR = 100 × (1 - (T2 / T1))
where T1 is the arithmetic mean EPG pre-treatment and T2 is the arithmetic mean EPG post-treatment [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. However, arithmetic means are sensitive to outliers and skewed distributions. The WAAVP now recommends using the geometric mean or, preferably, a generalized linear mixed model (GLMM) with a negative binomial distribution to account for overdispersion [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. The eggCounts package in R provides a Bayesian framework for FECRT analysis, incorporating hierarchical modeling and producing credible intervals for the reduction estimate [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-24">24</a>].
Thresholds for resistance classification are as follows:
| Reduction (%) | Interpretation |
|---|---|
| > 95% | Susceptible |
| 90-95% | Suspect (equivocal) |
| < 90% | Resistant |
These thresholds apply to most GINs in ruminants, but species-specific cutoffs exist. For example, in horses, a reduction < 90% for strongyles indicates resistance [<a href="#ref-10">10</a>, <a href="#ref-21">21</a>, <a href="#ref-25">25</a>]. For Fasciola hepatica, the WAAVP criteria for triclabendazole resistance require a reduction < 90% with lower confidence limit < 80% [<a href="#ref-8">8</a>, <a href="#ref-12">12</a>].
The use of confidence intervals is critical. A drug is considered effective only if the lower bound of the 95% confidence interval exceeds the resistance threshold [<a href="#ref-5">5</a>, <a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. Bootstrapping or Bayesian methods provide robust interval estimates even with small sample sizes [<a href="#ref-12">12</a>, <a href="#ref-24">24</a>, <a href="#ref-30">30</a>].
Factors Influencing FECRT Results
Numerous biological and technical factors can confound FECRT results.
Host Factors
Age, immune status, and nutritional condition affect egg excretion. Periparturient ewes and does exhibit a periparturient rise in EPG, which can reduce the apparent drug efficacy if not accounted for [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-28">28</a>]. Fasting prior to treatment can enhance benzimidazole efficacy [<a href="#ref-13">13</a>]. Concurrent disease or stress may alter drug metabolism [<a href="#ref-22">22</a>, <a href="#ref-31">31</a>].
Parasite Factors
Different nematode species vary in drug susceptibility. For instance, Cooperia oncophora is often less susceptible to macrocyclic lactones than Ostertagia ostertagi in cattle [<a href="#ref-4">4</a>, <a href="#ref-30">30</a>]. Haemonchus contortus frequently exhibits high-level resistance to multiple drug classes [<a href="#ref-7">7</a>, <a href="#ref-20">20</a>, <a href="#ref-27">27</a>]. The fecundity of female worms also influences EPG; resistant worms may produce fewer eggs, leading to overestimation of drug efficacy [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-19">19</a>].
Drug Factors
Formulation, route, and dose accuracy are critical. Pour-on applications may be less effective than injectable or oral routes due to variable absorption [<a href="#ref-7">7</a>, <a href="#ref-17">17</a>, <a href="#ref-26">26</a>]. Underdosing due to inaccurate weight estimation is a common cause of apparent resistance [<a href="#ref-3">3</a>, <a href="#ref-6">6</a>, <a href="#ref-8">8</a>]. Drug degradation or improper storage can also reduce efficacy [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-32">32</a>].
Environmental and Management Factors
Reinfection from contaminated pastures between sampling points can reduce the observed reduction, especially in grazing animals with high larval challenge [<a href="#ref-16">16</a>, <a href="#ref-18">18</a>, <a href="#ref-22">22</a>]. The FECRT should be performed when reinfection is minimal, such as during dry seasons or after moving animals to clean pasture [<a href="#ref-5">5</a>, <a href="#ref-31">31</a>, <a href="#ref-33">33</a>].
Advanced and Complementary Approaches
To overcome the limitations of the traditional FECRT, several advanced methods have been developed.
Molecular Confirmation of Resistance
Amplicon sequencing of the isotype-1 β-tubulin gene can detect single nucleotide polymorphisms (SNPs) associated with benzimidazole resistance in strongyles [<a href="#ref-15">15</a>, <a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. For macrocyclic lactone resistance, markers are less well defined, but nemabiome analysis (deep amplicon sequencing of the ITS-2 region) allows species-specific quantification of resistance alleles [<a href="#ref-9">9</a>, <a href="#ref-24">24</a>, <a href="#ref-33">33</a>]. Real-time PCR assays targeting resistant genotypes have been applied to H. contortus in sheep and goats [<a href="#ref-34">34</a>].
In Vitro Assays
The larval development assay (LDA) and egg hatch assay (EHA) provide in vitro measures of resistance that correlate with FECRT results [<a href="#ref-14">14</a>, <a href="#ref-24">24</a>, <a href="#ref-29">29</a>]. Automated larval motility assays using the WMicrotracker platform offer high-throughput phenotyping of drug susceptibility [<a href="#ref-20">20</a>, <a href="#ref-29">29</a>]. These assays can be used to confirm FECRT findings and to screen for resistance before treatment.
Integration with Targeted Selective Treatment
The FECRT is essential for monitoring the efficacy of targeted selective treatment (TST) programs, which aim to reduce anthelmintic use by treating only animals with high EPG or clinical signs (e.g., FAMACHA score for anemia) [<a href="#ref-16">16</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. Meta-analyses have shown that TST can maintain productivity while slowing the development of resistance [<a href="#ref-16">16</a>].
Bayesian and Hierarchical Modeling
The eggCounts model, implemented in R, provides a Bayesian framework that accounts for between-animal variability and produces more accurate resistance classifications than traditional methods [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-24">24</a>]. This approach is particularly useful when sample sizes are small or when EPG distributions are highly overdispersed.
FAQ
What is the fecal egg count reduction test?
The fecal egg count reduction test (FECRT) is an in vivo diagnostic method that compares the number of nematode eggs per gram of feces before and after anthelmintic treatment to determine drug efficacy and detect anthelmintic resistance [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>, <a href="#ref-5">5</a>].
How is the percent reduction calculated?
The percent reduction is calculated as 100 × (1 - (mean post-treatment EPG / mean pre-treatment EPG)), using arithmetic or geometric means, with modern guidelines recommending generalized linear mixed models or Bayesian approaches [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>].
What are the WAAVP thresholds for resistance?
The WAAVP thresholds are: >95% reduction indicates susceptibility, 90-95% indicates suspect resistance, and <90% indicates resistance for most gastrointestinal nematodes in ruminants [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Species-specific thresholds exist for horses and liver flukes [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-21">21</a>].
How many animals are needed for a reliable FECRT?
A minimum of 10 to 15 animals per treatment group is recommended, with pre-treatment EPG above a threshold (e.g., 150 EPG for sheep) to ensure statistical power [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-11">11</a>].
What factors can cause false-positive resistance results?
False-positive resistance can result from underdosing, inaccurate weight estimation, reinfection from pasture, improper drug storage, or sampling too early or too late after treatment [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-13">13</a>, <a href="#ref-17">17</a>].
How does the eggCounts model improve FECRT analysis?
The eggCounts model uses Bayesian hierarchical statistics to account for overdispersion and between-animal variability, providing more accurate confidence intervals and resistance classifications than traditional arithmetic mean calculations [<a href="#ref-10">10</a>, <a href="#ref-12">12</a>, <a href="#ref-24">24</a>].
Can molecular methods replace the FECRT?
Molecular methods such as β-tubulin genotyping and nemabiome analysis complement the FECRT by confirming resistance mechanisms and identifying species composition, but they do not replace the in vivo efficacy assessment [<a href="#ref-9">9</a>, <a href="#ref-15">15</a>, <a href="#ref-24">24</a>, <a href="#ref-34">34</a>].
What is the role of the FECRT in targeted selective treatment?
The FECRT is used to monitor the efficacy of anthelmintics in TST programs, ensuring that drugs remain effective against the parasite population and guiding decisions on treatment frequency and drug rotation [<a href="#ref-16">16</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>].